PharmaCielo Ltd. (TSXV:PCLO)

Market Cap	8.46M
Revenue (ttm)	3.48M
Net Income (ttm)	-9.14M
Shares Out	187.98M
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	74,615
Average Volume	62,077
Open	0.0500
Previous Close	0.0450
Day's Range	0.0450 - 0.0500
52-Week Range	0.0250 - 0.2300
Beta	1.88
RSI	42.31
Earnings Date	Aug 22, 2025

About Checkpoint Therapeutics

PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. Its products include medicinal-grade dried cannabis flower, cannabis oil extracts, tetrahydrocannabinol and cannabidiol medical cannabis, and other cannabis related products, as well as provides telemedicine software. The company also exports its products. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies. The company has strategic partnership with B...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Marc Lustig
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: PCLO

Financial Performance

In 2024, PharmaCielo's revenue was 3.48 million, an increase of 125.70% compared to the previous year's 1.54 million. Losses were -9.14 million, -43.91% less than in 2023.